KCPG
AGN

Kavar Capital Partners Group’s Allergan plc AGN Stock Holding History

Kavar Capital Partners Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-23
Closed -$7K – 452
2015
Q4 		$7K Sell
23
-1
-4% -$298 ﹤0.01% 283
2015
Q3 		$6K Sell
24
-31
-56% -$9.52K ﹤0.01% 303
2015
Q2 		$16K Buy
+55
New +$16.4K 0.01% 268

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Kavar Capital Partners Group's AGN Position: Q1 2016 in Review

Kavar Capital Partners Group sold out of Allergan plc (AGN) in Q1 2016, closing a stake of 23 shares — an estimated $7K sold.

Kavar Capital Partners Group first reported a position in AGN in Q2 2015 and held it in 3 quarters. The position peaked at $16K in Q2 2015. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • Kavar Capital Partners Group reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • Kavar Capital Partners Group sold 23 Allergan plc shares in Q1 2016, an estimated $7K.
  • Kavar Capital Partners Group first reported a position in Allergan plc in Q2 2015 and held it in 3 quarters.
  • Kavar Capital Partners Group's Allergan plc position peaked at $16K in Q2 2015.
  • 1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Kavar Capital Partners Group's 13F filing for Q1 2016, filed 13 May 2019.